Chargement en cours...
Biomarker predictors for immunotherapy benefit in breast: beyond PD-L1
PURPOSE OF REVIEW: Immune checkpoint blockade (ICB) has changed the clinical course of multiple cancer types and durable responses have now been observed in breast cancer (BC) patients. Most data suggest that, compared to other subtypes, triple-negative BC (TNBC) patients are more responsive to ICB,...
Enregistré dans:
| Publié dans: | Curr Breast Cancer Rep |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7731906/ https://ncbi.nlm.nih.gov/pubmed/33312343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-019-00331-5 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|